[1]
Bright, H.R. et al. 2023. Commentary on: “Chronic Use of Hydrochlorothiazide and Risk of Skin Cancer in Caucasian Adults: A PharmLines Initiative Inception Cohort Study. Acta Dermato-Venereologica. 103, (Aug. 2023), adv13348. DOI:https://doi.org/10.2340/actadv.v103.13348.